Veracyte (VCYT) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts VCYT Hot Sheet
Join SI Premium – FREE
Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.22), $0.03 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $18.33 million.
Veracyte reiterates its 2017 annual revenue guidance of $76 to $84 million and annual cash burn of $25 to $27 million.
For earnings history and earnings-related data on Veracyte (VCYT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prologis (PLD) Tops Q3 EPS by 8c; revises guidance
- AZZ, Inc. (AZZ) Tops Q2 EPS by 15c; raises guidance
- First Financial (FFIN) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
